WuXi Biologics (2269): Eigentümerstruktur
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 47 Hongkong Dollar | 54,45 Hongkong Dollar | 28,48 Hongkong Dollar |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 58,126 Hongkong Dollar | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 4.116.109.377 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name WuXi Biologics
Mitarbeiter 14.705
Handelsplatz HK
Ticker Symbol 2269
IPO Datum -
Adresse No. 108, Meiliang Road, Wuxi, China
Webseite https://www.wuxibiologics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Ge Li Ph.D. | Founder & Chairman |
| 2 | Dr. Zhisheng Chen Ph.D. | CEO & Executive Director |
| 3 | Dr. Xuejun Gu Ph.D. | CTO, Chief Client Officer, EVP of Global Biologics Development Department & Executive Director |
| 4 | Mr. Ming Tu | CFO & Executive VP |
| 5 | Lihua Yu M.B.A. | COO & Senior VP |
| 6 | Dr. Jijie Gu Ph.D. | Chief Scientific Officer & President of Global Biologics Research |
| 7 | Ms. Lina Fan Ph.D. | Senior VP & Head of Investor Relations |
| 8 | He Wang | General Counsel, Chief Compliance Officer, SVP and Head of Legal & Compliance Department |
| 9 | Xiaohui Liu M.B.A. | Executive VP & Chief Human Resources Officer |
| 10 | Mr. Jian Dong | CEO of WuXi Vaccines |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.